// App-Quantinova.ai

3705 : Differences in Outcomes in Males and Females with Diffuse Large B-Cell Lymphoma with Induction Rituximab and Follicular Lymphoma Treated with Maintenance Rituximab

Researchers

Presenter

  • Fangxin Hong

Principal Investigators

  • Vicki A. Morrison

  • Bruce A. Peterson

  • Howard S Hochster

  • Sandra J. Horning

  • Shaker R. Dakhil

  • James K. Weick

  • Stanley R. Frankel

  • Randy D. Gascoyne

  • Richard I Fisher

  • Bruce D. Cheson

  • Edie A. Weller

  • Brad S. Kahl

Medical Centers

  • VA Medical Center, Riviera Beach, FL

  • Hematology-Oncology, Georgetown University Hospital, Washington, DC, USA,

  • Department of Medical Oncology, BC Cancer Agency Center for Lymphoid Cancer, Vancouver, BC, Canada

Locations

  • United States

  • Canada

Companies

  • Feng Chi Biotech Cor

  • Genentech, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Follicular lymphoma

  • B-Cell Non-Hodgkin Lymphoma

  • B cell lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Vincristine

  • Adriamycin injection

  • Prednisone

  • Rituximab

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved